FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To establish whether the administration of FLOMAX® improves the outcome of a trial without
catheter (TWOC) after an episode of acute urinary retention and to determine whether
spontaneous voiding is maintained over the course of six months of active treatment